C-Squared Pharma India Profile
Key Indicators
- Authorised Capital ₹ 6.50 M
as on 03-12-2024
- Paid Up Capital ₹ 3.90 M
as on 03-12-2024
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 76.10%
(FY 2022)
- Ebitda 79.92%
(FY 2022)
- Net Worth -16.65%
(FY 2022)
- Total Assets -17.76%
(FY 2022)
About C-Squared Pharma India
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.50 M and a paid-up capital of Rs 3.90 M, as per Ministry of Corporate Affairs (MCA) records.
Andrew Badrot and Ragavendran Vasudevan serve as directors at the Company.
- CIN/LLPIN
U74999MH2019FTC323867
- Company No.
323867
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
09 Apr 2019
- Date of AGM
19 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at C-Squared Pharma India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Andrew Badrot  | Director | 09-Apr-2019 | Current |
Ragavendran Vasudevan  | Director | 05-Apr-2023 | Current |
Financial Performance of C-Squared Pharma India.
C-Squared Pharma India Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 76.1% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of C-Squared Pharma India?
In 2021, C-Squared Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at C-Squared Pharma India?
Unlock and access historical data on people associated with C-Squared Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of C-Squared Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped C-Squared Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
